AFTER THE BELL-Human Genome slides after offering plan

NEW YORK, Nov 30 (Reuters) - Shares of Human Genome Sciences Inc (HGSI.O) shares dropped 5.1 percent to $26.40 after the bell on Monday as the biotechnology company announced plans for a common stock offering. For details, see [ID:nWNAB0628] (Reporting by Ellis Mnyand; Editing by Dan Grebler) ((Ellis.Mnyandu@thomsonreuters.com; +1 646 223 6085; Reuters Messaging:ellis.mnyandu.reuters.com@reuters.net))